Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Harvard Review of Psychiatry

• Publication date

  2017-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/HRP.0000000000000122PMID 28272130PMCID PMC5518741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylphenidate for Attention-Deficit/Hyperactivity Disorder.

  2016cited by this paper
• Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.

  2015influential reference
• Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence

  2015cited by this paper
• Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.

  2015cited by this paper
• Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients

  2015cited by this paper
• The Brain on Drugs: From Reward to Addiction.

  2015cited by this paper
• The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders

  2014cited by this paper
• Pharmacological and clinical dilemmas of prescribing in co‐morbid adult attention‐deficit/hyperactivity disorder and addiction

  2014cited by this paper
• Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

  2014cited by this paper
• A Pilot Study of Lis-Dexamfetamine Dimesylate (LDX/SPD489) to Facilitate Smoking Cessation in Nicotine-Dependent Adults With ADHD

  2014cited by this paper
• The role of patient expectancy in placebo and nocebo effects in antidepressant trials.

  2014cited by this paper
• Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials

  2014cited by this paper
• Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

  2013influential reference
• Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial

  2013cited by this paper
• Do stimulants improve functioning in adults with ADHD? A review of the literature.

  2013cited by this paper
• Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.

  2013cited by this paper
• Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

  2013cited by this paper
• Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.

  2013cited by this paper
• New insights on neurobiological mechanisms underlying alcohol addiction.

  2013cited by this paper
• Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.

  2012cited by this paper
• Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.

  2012cited by this paper
• Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension

  2012cited by this paper
• The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders

  2012cited by this paper
• Addiction in Developmental Perspective: Influence of Conduct Disorder Severity, Subtype, and Attention-Deficit Hyperactivity Disorder on Problem Severity and Comorbidity in Adults with Opioid Dependence

  2012cited by this paper
• Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.

  2011cited by this paper
• Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

  2011cited by this paper
• Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses.

  2011cited by this paper
• Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate.

  2011cited by this paper
• Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults

  2011cited by this paper
• Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder

  2011cited by this paper
• A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder.

  2010cited by this paper
• Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

  2010cited by this paper
• Efficacy of meta-cognitive therapy for adult ADHD.

  2010cited by this paper
• A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

  2010cited by this paper
• Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.

  2010influential reference
• Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit

  2010cited by this paper
• Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.

  2010cited by this paper
• OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.

  2010cited by this paper
• Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.

  2010cited by this paper
• European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

  2010cited by this paper
• Effects of Psychiatric Comorbidity on Treatment Outcome in Patients Undergoing Diamorphine or Methadone Maintenance Treatment

  2010cited by this paper
• Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder

  2009cited by this paper
• Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients.

  2009cited by this paper
• Atomoxetine Treatment for Cocaine Abuse and Adult Attention Deficit/Hyperactivity Disorder (ADHD): A Preliminary Open Trial

  2009cited by this paper
• Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.

  2008cited by this paper
• Neuroplasticity in the mesolimbic dopamine system and cocaine addiction

  2008cited by this paper
• A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.

  2008cited by this paper
• Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder

  2008cited by this paper
• Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder

  2008cited by this paper
• Recent developments in the psychosocial treatment of adult ADHD

  2008cited by this paper
• A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disorders

  2008influential reference
• Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

  2008cited by this paper
• Treatment strategies for co-occurring ADHD and substance use disorders.

  2007cited by this paper
• Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

  2007cited by this paper
• Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.

  2007cited by this paper
• Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

  2006influential reference
• A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.

  2006cited by this paper
• Effectiveness outcomes in attention-deficit/hyperactivity disorder.

  2006cited by this paper
• Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.

  2005cited by this paper
• Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms.

  2005cited by this paper
• A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

  2005cited by this paper
• A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.

  2004cited by this paper
• Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community.

  2004cited by this paper
• Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder

  2004cited by this paper
• Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations

  2003cited by this paper
• Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort.

  2003cited by this paper
• Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence.

  2002cited by this paper
• Alcohol & Drug Abuse: Long-Acting Stimulants for the Treatment of Attention-Deficit Disorder in Cocaine-Dependent Adults

  2000cited by this paper
• Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.

  2000cited by this paper
• Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans

  1999cited by this paper
• Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment.

  1998cited by this paper
• Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study.

  1998cited by this paper
• Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype

  1997cited by this paper
• An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.

  1996cited by this paper
• The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.

  1995cited by this paper
• History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.

  1993cited by this paper
• Pemoline in attention deficit disorder and alcoholism: a case study.

  1983cited by this paper

• Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS).

  2026cites this paper
• Patterns of psychotropic medication use, medication switching, augmentation, and non-persistence in adolescents and young adults with co-occurring psychiatric morbidities and opioid use disorder.

  2026cites this paper
• Does Dexamphetamine Cause Addiction? A Narrative Review

  2025cites this paper
• Psychiatric comorbidity in substance use disorders, a systematic review of neuro-imaging findings.

  2025cites this paper
• The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis

  2025cites this paper
• Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial

  2024cites this paper
• Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS).

  2024cites this paper
• The effect of a single dose of methylphenidate on attention in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder

  2024cites this paper
• Trends in Attention-Deficit Hyperactivity Disorder Diagnosis and Pharmacotherapy Among Adults With Opioid Use Disorder.

  2023cites this paper
• Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorder

  2023influential citation
• Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study

  2023cites this paper
• Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency

  2022cites this paper
• ADHD and addictive behavior in crack-cocaine users.

  2022cites this paper
• Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD

  2022cites this paper
• Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View.

  2022cites this paper
• Managing Adult Attention-deficit/Hyperactivity Disorder With Comorbid Substance Use Disorder

  2022cites this paper
• Consensus international sur le dépistage, le diagnostic et le traitement des adolescents avec un trouble du déficit de l’attention avec ou sans hyperactivité en cas de comorbidité avec des troubles de l’usage de substances

  2022cites this paper
• Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder

  2022cites this paper
• The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study

  2022cites this paper
• Persistent Deficits in Self-Regulation as a Mediator between Childhood Attention-Deficit/Hyperactivity Disorder Symptoms and Substance Use Disorders

  2022cites this paper
• Oxazepam Detected in Urine 79 Days After Withdrawal of Diazepam: A Case Report.

  2021cites this paper
• Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice

  2021cites this paper
• Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study.

  2021cites this paper
• Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study

  2021influential citation
• Substanzgebundener Missbrauch und Abhängigkeit im Kindes- und Jugendalter

  2021cites this paper
• [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].

  2021cites this paper
• The Treatment of Adult ADHD: Complexity at Hand

  2020cites this paper
• Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.

  2020cites this paper
• Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017

  2020cites this paper
• Are non-abstinent reductions in World Health Organization drinking risk level a valid treatment target for alcohol use disorders in adolescents with ADHD?

  2020cites this paper
• Attention Deficit/Hyperactivity Disorder & Substance Abuse in Adults & Children

  2020cites this paper
• Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder.

  2020cites this paper
• Adult Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Systematic Review of the Literature

  2020cites this paper
• International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder

  2020cites this paper
• The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities

  2020cites this paper
• Adult ADHD in Substance-Related and Addictive Disorders

  2020cites this paper
• Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications.

  2019cites this paper
• Centrally acting stimulants in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017

  2019cites this paper
• Risks and benefits of ADHD medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases

  2019cites this paper
• Clinical and Neuropsychological Predictors of Methylphenidate Response in Children and Adolescents with ADHD: A Naturalistic Follow-up Study in a Spanish Sample

  2019cites this paper
• Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study

  2019cites this paper
• Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD

  2019cites this paper
• Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

  2019cites this paper
• Neurochemical Imaging in Addiction

  2019cites this paper
• Prescription Stimulant Use and Misuse: Implications for Responsible Prescribing Practices.

  2018cites this paper
• Treatment of adult ADHD: a clinical perspective

  2018cites this paper
• World Journal of Psychiatry

  year unknowncites this paper
• Advances in Complementary and Integrative Medicine

  year unknowninfluential citation